Skip to content

Synaptic mechanisms of therapeutic sleep deprivation in major depression

Synaptic mechanisms of therapeutic sleep deprivation in major depression

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00008014
Enrollment
45
Registered
2015-04-16
Start date
2015-04-16
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F32.2 F33.2

Interventions

Group 1: paired associative stimulation (PAS) after one night of therapeutic sleep deprivation in patients with major depressive disorder
PAS consists of 200 pairs of electrical and transcranial stimuli at a rate of 0.25 Hz with an interstimulus interval of 25 ms (duration ~ 13 min). Peripheral electrical stimulation is applied to the m

Sponsors

Universitätsklinikum FreiburgKlinik für Psychiatrie und Psychotherapie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: • Ages = 18 = 65 • Ability to provide informed consent • normal or corrected-to-normal vision • Absence of any exclusion criteria • Major depressive disorder (ICD-10: F32.2 and F33.2) • Score of =15 on the 21-item Hamilton Rating Scale for Depression (HAMD)

Exclusion criteria

Exclusion criteria: • Neurological disorders including epilepsy, history of brain injury, encephalitis, or any organic brain syndrome • metallic implants • present pregnancy • DSM-V axis I disorder (lifetime) apart from major depression, such as schizophrenia, schizoaffective disorder, any non-bipolar psychotic disorder, bipolar disorders, primary anxiety or obsessive compulsive disorder, mental retardation, signs of impaired cognitive functioning • Lifetime history for drug/alcohol dependence, or drug/alcohol abuse within the past year • Medication with any anxiolytic or antipsychotic drug, except antidepressants for patients • Medical conditions including severe cardiac, liver, kidney, endocrine (e.g., diabetes), hematologic disorders (e.g., porphyria or any bleeding abnormalities), other impairing or unstable medical condition or impending surgery • Primary sleep disorders diagnosed according to DSM-V criteria. • Inability to read or understand the study forms and agree to informed consent. • Irregular sleep schedules associated with shift work, frequent travel, or personal preference as indicated by weekly variation of >3 hours in bed time or wake time, or sleep duration 10 hours per night. • Left-handedness • Acute suicidality • Psychotic features of MDD • Excessive use of caffeine (>300 mg or three cups of coffee per day). • Excessive smoking (>10 cigarettes/day).

Design outcomes

Primary

MeasureTime frame
increase of the mean motor evoked potential (MEP) amplitude 30 min after paired associative stimulation (PAS) compared to baseline in the morning after one night of sleep deprivation

Secondary

MeasureTime frame
EEG theta power of the wake-EEG, mean reaction time in the Psychomotor Vigilance Task (PVT), recall performance in a declarative memory task (word-pair associates), BDNF genotype, BDNF serum level and salivary cortisol levels, transcranial magnetic stimulation (TMS) responses in non-responders to sleep deprivation. All examinations will take place in the morning after one night of therapeutic sleep deprivation.

Countries

Germany

Contacts

Public ContactChristoph Nissen

Universitätsklinikum FreiburgKlinik für Psychiatrie und Psychotherapie

christoph.nissen@uniklinik-freiburg.de076127065010

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026